This new textbook has an international authorship and is a practical, up-to-date resource for clinicians responsible for the care of children with oncologic and malignant hematologic disease. It is specifically designed for practicing oncologists and hematologists, pediatricians with an interest in childhood cancer and trainees seeking a systematic approach to these disorders. This new textbook has an emphasis on the visual presentation and ease of reading of contemporary and comprehensive information for children&;s cancers and contains detailed tables, fact boxes and illustrations.
The textbook begins with an introduction to the general principles of the scientific foundation and treatment of childhood cancers and hematological malignancies. Separate sections are then devoted to descriptions of central nervous system tumors, hematological malignancies and solid tumors of childhood which encompass epidemiology, cellular and molecular biology, cancer genetics, immunology, pharmacology and the findings of clinical trials. For each area of science covered, key original references and reviews are highlighted to direct further reading.
Diagnostic, biological, and therapeutic issues are integrated into each tumor-specific chapter, with evidence supporting the current rationales for risk stratification and the development of novel therapies. A final section then explores supportive care, palliative care, late effects considerations and psychosocial issues as relate to children&;s cancer.
Recenzijos
It is compact, concise, and easy to read and understand, and certainly a useful addition to the field. (Doody's, 3 August 2012) "However, overall, this is a useful book, probably most useful for paediatricians who may be providing shared care for paediatric oncology patients, junior doctors on haematology/oncolgy ward." (The Bulletin of the Royal College of Pathologists, 1 July 2011)
Contributors. 1 Introduction (Edward J. Estlin, Richard J. Gilbertson
and Robert F. Wynn). Part I Central Nervous System Tumors of Childhood. 2
Low- and High-Grade Glioma (Ian F. Pollack). 3 Ependymoma (Thomas E.
Merchant and Richard J. Gilbertson). 4 Embryonal Tumors (Amar Gajjar and
Steven C. Clifford). 5 Pediatric Spinal Cord Tumors (Annie Huang, Ute
Bartels and Eric Bouffet). 6 Pediatric Craniopharyngioma, Mixed Glioneuronal
Tumors, and Atypical Teratoid/Rhabdoid Tumor (Adrienne Weeks and Michael D.
Taylor). Part II Hematological Disorders. 7 Acute Lymphoblastic Leukemia
(Robert F. Wynn). 8 Acute Myeloid Leukemia and Myelodysplastic Disorders
(David K.H. Webb). 9 Non-Hodgkin s Lymphoma (Angelo Rosolen and Lara
Mussolin). 10 Hodgkin's Lymphoma (Wolfgang Dorffel and Dieter Korholz). 11
Histiocytic Disorders (Sheila Weitzman and R. Maarten Egeler). Part III
Solid Tumors of Childhood. 12 Neuroblastoma (Sucheta J. Vaidya and Andrew D.
J. Pearson). 13 Renal Tumors (Edward J. Estlin and Norbert Graf). 14 Soft
Tissue Sarcoma (Gianni Bisogno and John Anderson). 15 Bone Tumors (Richard
Gorlick, Martha Perisoglou and Jeremy Whelan). 16 Hepatic Tumors (Penelope
Brock, Derek J. Roebuck and Jack Plaschkes). 17 Germ Cell Tumors (James
Nicholson and Roger Palmer). 18 Retinoblastoma (Edward J. Estlin, Francois
Doz and Michael Dyer). 19 Rare Tumors (Bernadette Brennan and Charles
Stiller). Part IV Supportive Care, Long-Term Issues, and Palliative Care.
20 Supportive Care: Physical Consequences of Cancer and its Therapies (Bob
Phillips and Roderick Skinner). 21 Psychosocial Needs of Children with
Cancer and Their Families (Ged Lalor and Louise Talbot). 22 Late Effects in
Relation to Childhood Cancer (Louise Talbot and Helen Spoudeas). 23
Palliative Care (Lynda Brook). 24 Clinical Trials Involving Children with
Cancer Organizational and Ethical Issues (Sue Ablett and Edward J.
Estlin). Index. Colour plate.
Edward J. Estlin, BSc (Hons), PhD, MRCP, FRCPCH Macmillan Consultant in Paediatric Oncology, Department of Paediatric Oncology, Royal Manchester Children s Hospital, Manchester, UK Richard J. Gilbertson, B.Med.Sci (Hons), MRCP, PhD Co-Leader, Neurobiology and Brain Tumor Program; Director, Molecular Clinical Trials Core, Departments of Developmental Neurobiology and Oncology, St Jude Children s Research Hospital, Memphis, TN, USA Robert F. Wynn, BA, MD, MRCP, FRCPath Consultant Paediatric Haematologist and Programme Director, Blood and Marrow Transplant Unit, Royal Manchester Children s Hospital, Manchester, UK
